Lv1
20 积分 2022-11-11 加入
Natalizumab exacerbates astrocytopathy in NMOSD via blockade of endothelial VCAM1–astrocytic integrin α4 interaction
24天前
已完结
Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial
1个月前
已完结
Safety and efficacy of inebilizumab for the treatment of neuromyelitis optica spectrum disorder: end-of-study results from the open-label period of the N-MOmentum trial
1个月前
已完结
Relapses during treatment with monoclonal antibodies targeting B-cells in NMOSD
1个月前
已完结
Therapeutic immune tolerance for central nervous system autoimmune diseases – Prospects, challenges and pitfalls
1个月前
已关闭
Relapses during treatment with monoclonal antibodies targeting B-cells in NMOSD
1个月前
已完结
Multi-omics reveals Fuyuan Xingnao Decoction's therapeutic mechanism in cerebral infararction via gut microbiota and JAK2-STAT3 pathway
5个月前
已完结
Current imaging applications, radiomics, and machine learning modalities of CNS demyelinating disorders and its mimickers
6个月前
已完结
(+)-Borneol enhances the protective effect of edaravone against cerebral ischemia/reperfusion injury by targeting OAT3/P-gp transporters for drug delivery into the brain
6个月前
已完结
Edaravone Dexborneol Attenuates Cerebral Ischemia–Reperfusion Injury via cGAS–STING Inhibition, STX17-Mediated Autophagic Flux Restoration, and NLRP3 Inflammasome Suppression
6个月前
已完结
皖公网安备34019202002308
